New ‘Trojan Horse’ Cancer Drug Successfully Treats Patients With 6 Different Kinds of Lethal Tumors

A brand new type of cancer drug that acts as a “Trojan horse” to get inside tumor cells has shown promise in patients with advanced, drug-resistant cancers. Patients with six different cancer types, including those with cervical, bladder, ovarian and lung tumors, have responded positively to the new treatment. Since these patients had already exhausted their other treatment options, the drug could be ready to extend their lifespans within the next five years. The innovative new drug, called tisotumab vedotin (or TV for short), releases a toxic substance to kill cancer cells from within. The results have been so positive, the drug has now moved forward to phase II trials in cervical cancer and will be tested in a range of additional solid tumor cancers. MORE: Boy is Cured of Aggressive Cancer Thanks to Stem Cell Treatment Using Donated Umbilical Cord A team at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust led a phase I/II global clinical trial of nearly 150 European patients with a variety of cancer types who had stopped responding to standard treatments. Read more here >>>

thumbnail courtesy of


Please enter your comment!
Please enter your name here